Quadpoint Labs provides a cloud‑based AI virtual lab that lets users perform a 2‑minute at‑home stool test for early detection of colorectal cancer, precancerous lesions, and other gastrointestinal conditions. The disposable lateral‑flow device captures biomarker results via a smartphone, which are analyzed in the cloud to deliver real‑time, personalized risk assessments and secure reports that integrate with medical records.
Funding
Funding not disclosed
Founders
Product
Problem
Colorectal cancer and other gastrointestinal conditions are often detected late because traditional screening requires clinic visits, lab processing, and specialized equipment, leading to low adherence and delayed diagnosis.
Solution
Quadpoint Labs offers a cloud‑based AI virtual lab that enables users to perform a 2‑minute, at‑home stool test every three months. The disposable lateral‑flow device produces a dot‑matrix result that is captured with a smartphone and uploaded to the cloud. An AI engine analyzes multiple biomarkers, compares results against the user’s risk profile and historical data, and delivers quantitative, real‑time insights. The QuadPoint Health app guides sample collection, provides 24/7 AI support, generates a personalized medical summary, and shares results securely with the user’s physician for follow‑up. This workflow delivers lab‑grade diagnostics without a physical lab visit, improving privacy, convenience, and adherence to preventive screening.
Target Audience
Primary customers are health‑conscious individuals and patients at risk for colorectal cancer who prefer home‑based screening, as well as healthcare providers and insurers seeking scalable preventive‑care solutions.
Features
- Disposable passive lateral‑flow sensor that produces a multi‑target dot‑matrix output readable by a smartphone camera
- AI‑driven image analysis in the cloud that quantifies multiple colorectal cancer and precancer biomarkers within minutes
- Longitudinal risk assessment that incorporates each test’s results and the user’s personal risk profile
- Mobile app with step‑by‑step guidance, real‑time result interpretation, and 24/7 AI chat support
- Secure, HIPAA‑compliant data transmission and automatic integration of reports into the user’s electronic medical record
- Scalable manufacturing through a CDMO partnership ensuring regulatory alignment and consistent test quality